7[7]Pasceri V.Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-grmma activators[J].Circulation,2000,101:235-238.
8[8]Fonseca V.Once-daily rosiglitazone in combination with metformin efectively reduces hyperglycemia in patients with type 2 diabetes[J].Diabetes,1999,48(Suppl 1):A100-108.
4Hwang C S，Proc Nat Acad Sci SUA，1996年，93卷，2期，873页
5Zhang F，Hypertension，1994年，24卷，2期，170页
6Borkman M，New England J Medicine，1993年，328卷，4期，238页
7Xie M Z，药学学报，1985年，20卷，11期，801页
8Kruszynska YT, Yu JG, Olefsky JM, et al. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects. Diabetes, 2000,49 : 633-639.
9Willson TM, Brown PJ, Sternbach DD, et al. The PPARs:from orphan receptors to drug discovery. J Med Chem,2000,43:527-550.
10Olefsky JM. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists. J Clin Invest,2000,106:467-472.
